DrugPatentWatch Database Preview
Unique Pharm Labs Company Profile
What is the competitive landscape for UNIQUE PHARM LABS, and what generic and branded alternatives to UNIQUE PHARM LABS drugs are available?
UNIQUE PHARM LABS has twelve approved drugs.
Summary for Unique Pharm Labs
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 12 |
Drugs and US Patents for Unique Pharm Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unique Pharm Labs | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076957-002 | Sep 28, 2005 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Unique Pharm Labs | DICLOFENAC SODIUM | diclofenac sodium | TABLET, DELAYED RELEASE;ORAL | 090066-002 | Dec 1, 2010 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Unique Pharm Labs | CETIRIZINE HYDROCHLORIDE HIVES | cetirizine hydrochloride | TABLET;ORAL | 077829-002 | Aug 26, 2009 | OTC | No | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Unique Pharm Labs | TINIDAZOLE | tinidazole | TABLET;ORAL | 202489-002 | Oct 9, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Unique Pharm Labs | GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 204720-003 | Dec 29, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Unique Pharm Labs | DICLOFENAC SODIUM | diclofenac sodium | TABLET, DELAYED RELEASE;ORAL | 077863-003 | Jun 8, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Unique Pharm Labs | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076957-003 | Sep 28, 2005 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
